Anti‐viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus‐related hepatocellular carcinoma: real‐world east and west experience |
| |
| Authors: | V. L. Chen,M.‐L. Yeh,A. K. Le,M. Jun,W. K. Saeed,J. D. Yang,C.‐F. Huang,H. Y. Lee,P.‐C. Tsai,M.‐H. Lee,N. Giama,N. G. Kim,P. P. Nguyen,H. Dang,H. A. Ali,N. Zhang,J.‐F. Huang,C.‐Y. Dai,W.‐L. Chuang,L. R. Roberts,D. W. Jun,Y.‐S. Lim,M.‐L. Yu,M. H. Nguyen |
| |
| Affiliation: | 1. Division of Gastroenterology, University of Michigan Health System, Ann Arbor, MI, USA;2. Department of Medicine, Stanford University Medical Center, Stanford, CA, USA;3. Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan;4. Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA, USA;5. Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;6. Division of Gastroenterology, Hanyang University Medical Center, Seoul, Korea;7. Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA;8. Institute of Clinical Medicine, National Yang‐Ming University, Taipei, Taiwan;9. Stanford University School of Medicine, Stanford, CA, USA |
| |
| Abstract: | |
| |
| Keywords: | |
|
|
